A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 7, 2006, Pages 773-776

  Layton, Alison M ^a   Dreno, B ^b   Gollnick, H P M ^c   Zouboulis, C C ^d  

^a HARROGATE AND DISTRICT NHS FOUNDATION TRUST   (United Kingdom)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d DESSAU MEDICAL CENTER   (Germany)

Author keywords

Acne vulgaris; European Directive; Isotretinoin; Pregnancy prevention

Indexed keywords

ANTIBIOTIC AGENT; CONTRACEPTIVE AGENT; ETHINYLESTRADIOL; ISOTRETINOIN; ORAL CONTRACEPTIVE AGENT; TOPICAL AGENT;

ACNE VULGARIS; CLINICAL PRACTICE; DEPRESSION; DERMATOLOGY; DRUG DOSE REGIMEN; EDITORIAL; EUROPE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE FINANCING; HUMAN; MEDICAL SPECIALIST; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; SUICIDAL IDEATION; VENOUS THROMBOEMBOLISM;

ACNE VULGARIS; ADMINISTRATION, ORAL; EUROPE; HUMANS; ISOTRETINOIN; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33746288074     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01671.x     Document Type: Editorial

References (3)

1. MHRA. Current problems in pharmacovigilance. Drug Safety Bulletin of the MHRA and CHM. 'Tamoxifen and venous thromboembolism'. Oct 2002; 28: 9.
2. Cunliffe WJ, van der Kerkhof PCH, Capeto R et al. Roaccutane treatment guidelines: Results of an international study. Dermatology 1999; 198: 404-406.
3. Goulden V, Clark SM, McGeown C, Cunliffe WJ. Treatment of acne with intermittent isotretinoin. Br J Dermatol 1997; 137: 106-108.